Acrivon Therapeutics

Acrivon Therapeutics

Biotech company specializing in drug development through early clinical treatment success.

HQ location
Cambridge, United States
Launch date
Employees
Market cap
$42.8m
Enterprise value
($91m)
Share price
$1.33 ACRV
Authorizing premium user...